168 related articles for article (PubMed ID: 7859934)
1. Kinin, a mediator of diabetes-induced glomerular hyperfiltration.
Jaffa AA; Rust PF; Mayfield RK
Diabetes; 1995 Feb; 44(2):156-60. PubMed ID: 7859934
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor I produces renal hyperfiltration by a kinin-mediated mechanism.
Jaffa AA; LeRoith D; Roberts CT; Rust PF; Mayfield RK
Am J Physiol; 1994 Jan; 266(1 Pt 2):F102-7. PubMed ID: 8304475
[TBL] [Abstract][Full Text] [Related]
3. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Vora JP; Oyama TT; Thompson MM; Anderson S
Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
[TBL] [Abstract][Full Text] [Related]
4. Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins.
Komers R; Cooper ME
Am J Physiol; 1995 Apr; 268(4 Pt 2):F588-94. PubMed ID: 7733315
[TBL] [Abstract][Full Text] [Related]
5. Evidence for renal kinins as mediators of amino acid-induced hyperperfusion and hyperfiltration in the rat.
Jaffa AA; Vio CP; Silva RH; Vavrek RJ; Stewart JM; Rust PF; Mayfield RK
J Clin Invest; 1992 May; 89(5):1460-8. PubMed ID: 1373739
[TBL] [Abstract][Full Text] [Related]
6. Renal hyperfiltration states: relationship to kallikrein and kinins.
Mayfield RK; Jaffa AA; Edmundson AW; Harvey JN
Agents Actions Suppl; 1992; 38 ( Pt 3)():142-8. PubMed ID: 1281377
[TBL] [Abstract][Full Text] [Related]
7. Modulation of renal kallikrein production by dietary protein in streptozotocin-induced diabetic rats.
Jaffa AA; Silva RH; Kim B; Mayfield RK
J Am Soc Nephrol; 1996 May; 7(5):721-7. PubMed ID: 8738807
[TBL] [Abstract][Full Text] [Related]
8. Reduction of glomerular hyperfiltration by dopamine D(2)-like receptor blockade in experimental diabetes mellitus.
Luippold G; Beilharz M; Mühlbauer B
Nephrol Dial Transplant; 2001 Jul; 16(7):1350-6. PubMed ID: 11427624
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of neuronal nitric oxide synthase ameliorates renal hyperfiltration in streptozotocin-induced diabetic rat.
Ito A; Uriu K; Inada Y; Qie YL; Takagi I; Ikeda M; Hashimoto O; Suzuka K; Eto S; Tanaka Y; Kaizu K
J Lab Clin Med; 2001 Sep; 138(3):177-85. PubMed ID: 11528370
[TBL] [Abstract][Full Text] [Related]
10. Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats.
Tschöpe C; Reinecke A; Seidl U; Yu M; Gavriluk V; Riester U; Gohlke P; Graf K; Bader M; Hilgenfeldt U; Pesquero JB; Ritz E; Unger T
Am J Physiol; 1999 Dec; 277(6):H2333-40. PubMed ID: 10600853
[TBL] [Abstract][Full Text] [Related]
11. Role of kinins in the renal response to enalaprilat in normotensive and hypertensive rats.
Fitzgibbon WR; Jaffa AA; Mayfield RK; Ploth DW
Hypertension; 1996 Feb; 27(2):235-44. PubMed ID: 8567046
[TBL] [Abstract][Full Text] [Related]
12. Contrasting effects of acute insulin infusion on renal function in awake nondiabetic and diabetic rats.
Tucker BJ; Mendonca MM; Blantz RC
J Am Soc Nephrol; 1993 Apr; 3(10):1686-93. PubMed ID: 8318685
[TBL] [Abstract][Full Text] [Related]
13. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
14. Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes.
Komers R; Allen TJ; Cooper ME
Diabetes; 1994 Oct; 43(10):1190-7. PubMed ID: 7926287
[TBL] [Abstract][Full Text] [Related]
15. Antagonist for atrial natriuretic peptide receptors ameliorates glomerular hyperfiltration in diabetic rats.
Kikkawa R; Haneda M; Sakamoto K; Koya D; Shikano T; Nakanishi S; Matsuda Y; Shigeta Y
Biochem Biophys Res Commun; 1993 Jun; 193(2):700-5. PubMed ID: 8390251
[TBL] [Abstract][Full Text] [Related]
16. Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist.
Sakamoto K; Kikkawa R; Haneda M; Shigeta Y
Diabetologia; 1995 May; 38(5):536-42. PubMed ID: 7489835
[TBL] [Abstract][Full Text] [Related]
17. Effects of a kinin antagonist on renal function in rats.
Nakagawa M; Stewart JM; Vavrek RJ; Nasjletti A
Am J Physiol; 1990 Mar; 258(3 Pt 2):F643-8. PubMed ID: 1690517
[TBL] [Abstract][Full Text] [Related]
18. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.
Braun C; Kleemann T; Hilgenfeldt U; Riester U; Rohmeiss P; van der Woude FJ
Kidney Int; 2002 Jun; 61(6):2149-56. PubMed ID: 12028455
[TBL] [Abstract][Full Text] [Related]
19. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
[TBL] [Abstract][Full Text] [Related]
20. Vasoregulatory hormones and the hyperfiltration of diabetes.
Bank N; Lahorra MA; Aynedjian HS; Schlondorff D
Am J Physiol; 1988 Feb; 254(2 Pt 2):F202-9. PubMed ID: 2449821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
